[ad_1]
The agency said the combination would hurt competition for cancer-detection tests while raising prices.
[ad_2]
Source link
FTC Rejects Illumina’s $7 Billion Deal for Cancer-Test Developer Grail
April 21, 2025
[ad_1]
The agency said the combination would hurt competition for cancer-detection tests while raising prices.
[ad_2]
Source link
